Brazil · Delayed Price · Currency is BRL Amgen Statistics
Total Valuation
Amgen has a market cap or net worth of BRL 990.89 billion. The enterprise value is 1.24 trillion.
| Market Cap | 990.89B |
| Enterprise Value | 1.24T |
Important Dates
The next estimated earnings date is Thursday, April 30, 2026.
| Earnings Date | Apr 30, 2026 |
| Ex-Dividend Date | Feb 12, 2026 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.19% |
| Shares Change (QoQ) | +0.18% |
| Owned by Insiders (%) | 0.17% |
| Owned by Institutions (%) | 81.91% |
| Float | 537.59M |
Valuation Ratios
The trailing PE ratio is 23.33 and the forward PE ratio is 15.52.
| PE Ratio | 23.33 |
| Forward PE | 15.52 |
| PS Ratio | 4.90 |
| PB Ratio | 20.78 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 22.21 |
| P/OCF Ratio | 18.07 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.86, with an EV/FCF ratio of 27.70.
| EV / Earnings | 29.09 |
| EV / Sales | 6.36 |
| EV / EBITDA | 13.86 |
| EV / EBIT | 20.20 |
| EV / FCF | 27.70 |
Financial Position
The company has a current ratio of 1.14, with a Debt / Equity ratio of 6.40.
| Current Ratio | 1.14 |
| Quick Ratio | 0.73 |
| Debt / Equity | 6.40 |
| Debt / EBITDA | 3.29 |
| Debt / FCF | 6.84 |
| Interest Coverage | 3.66 |
Financial Efficiency
Return on equity (ROE) is 106.10% and return on invested capital (ROIC) is 18.12%.
| Return on Equity (ROE) | 106.10% |
| Return on Assets (ROA) | 7.93% |
| Return on Invested Capital (ROIC) | 18.12% |
| Return on Capital Employed (ROCE) | 17.78% |
| Weighted Average Cost of Capital (WACC) | 6.19% |
| Revenue Per Employee | 6.43M |
| Profits Per Employee | 1.35M |
| Employee Count | 31,500 |
| Asset Turnover | 0.40 |
| Inventory Turnover | 1.62 |
Taxes
In the past 12 months, Amgen has paid 6.97 billion in taxes.
| Income Tax | 6.97B |
| Effective Tax Rate | 14.09% |
Stock Price Statistics
The stock price has increased by +1.19% in the last 52 weeks. The beta is 0.43, so Amgen's price volatility has been lower than the market average.
| Beta (5Y) | 0.43 |
| 52-Week Price Change | +1.19% |
| 50-Day Moving Average | 66.88 |
| 200-Day Moving Average | 60.27 |
| Relative Strength Index (RSI) | 40.48 |
| Average Volume (20 Days) | 665 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 5.57 |
Income Statement
In the last 12 months, Amgen had revenue of BRL 202.42 billion and earned 42.47 billion in profits. Earnings per share was 78.38.
| Revenue | 202.42B |
| Gross Profit | 143.29B |
| Operating Income | 63.75B |
| Pretax Income | 49.44B |
| Net Income | 42.47B |
| EBITDA | 91.53B |
| EBIT | 63.75B |
| Earnings Per Share (EPS) | 78.38 |
Balance Sheet
The company has 50.28 billion in cash and 305.34 billion in debt, with a net cash position of -255.05 billion.
| Cash & Cash Equivalents | 50.28B |
| Total Debt | 305.34B |
| Net Cash | -255.05B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 47.69B |
| Book Value Per Share | 88.51 |
| Working Capital | 19.65B |
Cash Flow
In the last 12 months, operating cash flow was 54.85 billion and capital expenditures -10.23 billion, giving a free cash flow of 44.61 billion.
| Operating Cash Flow | 54.85B |
| Capital Expenditures | -10.23B |
| Depreciation & Amortization | 26.80B |
| Net Borrowing | -30.20B |
| Free Cash Flow | 44.61B |
| FCF Per Share | n/a |
Margins
Gross margin is 70.78%, with operating and profit margins of 31.49% and 20.98%.
| Gross Margin | 70.78% |
| Operating Margin | 31.49% |
| Pretax Margin | 24.42% |
| Profit Margin | 20.98% |
| EBITDA Margin | 45.22% |
| EBIT Margin | 31.49% |
| FCF Margin | 22.04% |
Dividends & Yields
This stock pays an annual dividend of 1.25, which amounts to a dividend yield of 1.92%.
| Dividend Per Share | 1.25 |
| Dividend Yield | 1.92% |
| Dividend Growth (YoY) | -0.37% |
| Years of Dividend Growth | 12 |
| Payout Ratio | 66.45% |
| Buyback Yield | -0.19% |
| Shareholder Yield | 1.73% |
| Earnings Yield | 4.29% |
| FCF Yield | 4.50% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on October 29, 2020. It was a forward split with a ratio of 28.
| Last Split Date | Oct 29, 2020 |
| Split Type | Forward |
| Split Ratio | 28 |
Scores
Amgen has an Altman Z-Score of 1.65 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.65 |
| Piotroski F-Score | 7 |